Germany
Japan
United Kingdom
China
CACHD1 (myc-DDK-tagged) - Human cache domain containing 1 (CACHD1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Expression Plasmids
DownloadSEL1L3 (myc-DDK-tagged) - Human sel-1 suppressor of lin-12-like 3 (C. elegans) (SEL1L3), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
EPHA7 (myc-DDK-tagged) - Human EPH receptor A7 (EPHA7), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
EPHA5 (myc-DDK-tagged) - Human EPH receptor A5 (EPHA5), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC24A1 (myc-DDK-tagged) - Human solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 (SLC24A1), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
EPHA5 (myc-DDK-tagged) - Human EPH receptor A5 (EPHA5), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
LRP5 (myc-DDK-tagged) - Human low density lipoprotein receptor-related protein 5 (LRP5), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PCDH11Y (myc-DDK-tagged) - Human protocadherin 11 Y-linked (PCDH11Y), transcript variant d
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
EPHA5 (myc-DDK-tagged) - Human EPH receptor A5 (EPHA5), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SEMA6A (myc-DDK-tagged) - Human sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A (SEMA6A), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ITGA8 (myc-DDK-tagged) - Human integrin, alpha 8 (ITGA8), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ERBB2 (myc-DDK-tagged) - Human erb-b2 receptor tyrosine kinase 2 (ERBB2), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
KCNT2 (myc-DDK-tagged) - Human potassium channel, subfamily T, member 2 (KCNT2), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC24A1 (myc-DDK-tagged) - Human solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 (SLC24A1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PCDH1 (myc-DDK-tagged) - Human protocadherin 1 (PCDH1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TEK (myc-DDK-tagged) - Human TEK tyrosine kinase, endothelial (TEK), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SLC24A1 (myc-DDK-tagged) - Human solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 (SLC24A1), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SEL1L3 (myc-DDK-tagged) - Human sel-1 suppressor of lin-12-like 3 (C. elegans) (SEL1L3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BOC (myc-DDK-tagged) - Human BOC cell adhesion associated, oncogene regulated (BOC), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
LPHN2 (myc-DDK-tagged) - Human latrophilin 2 (LPHN2), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TEX2 (myc-DDK-tagged) - Human testis expressed 2 (TEX2), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TEX2 (myc-DDK-tagged) - Human testis expressed 2 (TEX2), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PCDH18 (myc-DDK-tagged) - Human protocadherin 18 (PCDH18), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ITGAX (myc-DDK-tagged) - Human integrin, alpha X (complement component 3 receptor 4 subunit) (ITGAX), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CHL1 (myc-DDK-tagged) - Human cell adhesion molecule L1-like (CHL1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
LPHN2 (myc-DDK-tagged) - Human latrophilin 2 (LPHN2), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
USD 1,250.00
5 Weeks
GRM1 (myc-DDK-tagged) - Human glutamate receptor, metabotropic 1 (GRM1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
FNDC3A (myc-DDK-tagged) - Human fibronectin type III domain containing 3A (FNDC3A), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ASTN1 (myc-DDK-tagged) - Human astrotactin 1 (ASTN1), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ERBB2 (myc-DDK-tagged) - Human erb-b2 receptor tyrosine kinase 2 (ERBB2), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
IGF1R (myc-DDK-tagged) - Human insulin-like growth factor 1 receptor (IGF1R), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ROBO2 (myc-DDK-tagged) - Human roundabout, axon guidance receptor, homolog 2 (Drosophila) (ROBO2), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
LPHN2 (myc-DDK-tagged) - Human latrophilin 2 (LPHN2), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ATP7A (myc-DDK-tagged) - Human ATPase, Cu++ transporting, alpha polypeptide (ATP7A), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
IGSF9B (myc-DDK-tagged) - Human immunoglobulin superfamily, member 9B (IGSF9B)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PTPRK (myc-DDK-tagged) - Human protein tyrosine phosphatase, receptor type, K (PTPRK), transcript variant 6
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ROBO2 (myc-DDK-tagged) - Human roundabout, axon guidance receptor, homolog 2 (Drosophila) (ROBO2), transcript variant 4
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
PTPRK (myc-DDK-tagged) - Human protein tyrosine phosphatase, receptor type, K (PTPRK), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
CD163L1 (myc-DDK-tagged) - Human CD163 molecule-like 1 (CD163L1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ADCY10 (myc-DDK-tagged) - Human adenylate cyclase 10 (soluble) (ADCY10), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
BAI2 (myc-DDK-tagged) - Human brain-specific angiogenesis inhibitor 2 (BAI2), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ABCA8 (myc-DDK-tagged) - Human ATP-binding cassette, sub-family A (ABC1), member 8 (ABCA8), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
ABCA8 (myc-DDK-tagged) - Human ATP-binding cassette, sub-family A (ABC1), member 8 (ABCA8), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SCN11A (myc-DDK-tagged) - Human sodium channel, voltage-gated, type XI, alpha subunit (SCN11A), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SCN10A (myc-DDK-tagged) - Human sodium channel, voltage-gated, type X, alpha subunit (SCN10A), transcript variant 3
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TRPM7 (myc-DDK-tagged) - Human transient receptor potential cation channel, subfamily M, member 7 (TRPM7), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
SCN10A (myc-DDK-tagged) - Human sodium channel, voltage-gated, type X, alpha subunit (SCN10A), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
OTOF (myc-DDK-tagged) - Human otoferlin (OTOF), transcript variant 5
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TRPV1 (Myc-DDK-tagged)-Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Active filters
Category
-
cDNA Clones
- Expression Plasmids
Species
- Human
Vectors
- pCMV6-Entry
Mutants
- No
Families
- Transmembrane
Brands
- TrueORF
Filter by
Target Symbol
- CACNA1G (28)
- UTY (25)
- CACNA1C (23)
- MUC1 (20)
- OPRM1 (19)
- NRG1 (18)
- ST3GAL3 (18)
- BDNF (17)
- DYSF (14)
- CD1E (13)
- DAG1 (13)
- ELN (13)
- ASPH (12)
- CD46 (12)
- LINGO1 (12)
- MYADM (12)
- PAQR6 (12)
- PCDH15 (12)
- PGAP2 (12)
- ADGRG1 (11)
- ATP2C1 (11)
- BCL2L13 (11)
- FGFR1 (11)
- GHR (11)
- TMEM218 (11)
- ZNF33A (11)
- APP (10)
- CLEC4M (10)
- FGFR2 (10)
- GHRL (10)
- HFE (10)
- IFI27 (10)
- OPALIN (10)
- SLAMF7 (10)
- SLC50A1 (10)
- ADAM15 (9)
- ADGRG2 (9)
- AGER (9)
- CDH23 (9)
- CSF2RA (9)
- DDR1 (9)
- FCAR (9)
- HMOX2 (9)
- KCNMA1 (9)
- MFF (9)
- MOG (9)
- P2RY6 (9)
- PTGER3 (9)
- SLC35B2 (9)
- SPOCK3 (9)
- TMEM254 (9)
- TMEM9 (9)
- TRPM3 (9)
- VRK2 (9)
- ANK1 (8)
- BAX (8)
- C1ORF43 (8)
- CCL4L2 (8)
- CD36 (8)
- CD44 (8)
- CD63 (8)
- CHRM2 (8)
- CMTM1 (8)
- FXYD3 (8)
- GRM4 (8)
- KCNE1 (8)
- KCNJ15 (8)
- KCNJ16 (8)
- LDLRAD4 (8)
- MIA2 (8)
- OS9 (8)
- P2RX2 (8)
- RHD (8)
- SLC35A2 (8)
- SLITRK2 (8)
- STRA6 (8)
- TMEM139 (8)
- ACBD5 (7)
- ADAM29 (7)
- ATP2A3 (7)
- C19ORF12 (7)
- CADM2 (7)
- CCDC51 (7)
- CD300LF (7)
- CPT1B (7)
- CUX1 (7)
- DIABLO (7)
- ENTPD1 (7)
- FCRLA (7)
- GABRA1 (7)
- GPR161 (7)
- GRIA1 (7)
- GSG1 (7)
- HTR4 (7)
- IL31RA (7)
- IL5RA (7)
- ITGB6 (7)
- LILRB4 (7)
- LYSMD4 (7)
- MFSD11 (7)
Tags
Mammalian Cell Selection
Pathways
- Metabolic pathways (621)
- Neuroactive ligand-receptor interaction (507)
- Cytokine-cytokine receptor interaction (355)
- Olfactory transduction (342)
- Calcium signaling pathway (287)
- Cell adhesion molecules (CAMs) (267)
- MAPK signaling pathway (194)
- Hematopoietic cell lineage (172)
- Pathways in cancer (165)
- Alzheimer's disease (143)
- Dilated cardiomyopathy (122)
- Jak-STAT signaling pathway (120)
- Natural killer cell mediated cytotoxicity (109)
- Vascular smooth muscle contraction (109)
- Hypertrophic cardiomyopathy (HCM) (108)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (106)
- Regulation of actin cytoskeleton (102)
- Lysosome (100)
- Axon guidance (99)
- ECM-receptor interaction (88)
- Antigen processing and presentation (85)
- Huntington's disease (84)
- Chemokine signaling pathway (83)
- Endocytosis (83)
- ABC transporters (82)
- Cardiac muscle contraction (79)
- Focal adhesion (77)
- N-Glycan biosynthesis (77)
- Oxidative phosphorylation (77)
- Viral myocarditis (77)
- Type II diabetes mellitus (74)
- Leukocyte transendothelial migration (72)
- Drug metabolism - cytochrome P450 (69)
- Parkinson's disease (65)
- Adipocytokine signaling pathway (62)
- GnRH signaling pathway (62)
- Retinol metabolism (62)
- Glycosphingolipid biosynthesis - lacto and neolacto series (61)
- Systemic lupus erythematosus (61)
- Metabolism of xenobiotics by cytochrome P450 (59)
- SNARE interactions in vesicular transport (59)
- Adherens junction (58)
- PPAR signaling pathway (58)
- Long-term potentiation (57)
- Autoimmune thyroid disease (55)
- Graft-versus-host disease (55)
- Purine metabolism (55)
- Melanogenesis (54)
- Taste transduction (51)
- ErbB signaling pathway (49)
- Glycerophospholipid metabolism (49)
- Colorectal cancer (48)
- Neurotrophin signaling pathway (48)
- Drug metabolism - other enzymes (47)
- Gap junction (47)
- Tight junction (47)
- Type I diabetes mellitus (47)
- Allograft rejection (46)
- Apoptosis (46)
- Long-term depression (46)
- Starch and sucrose metabolism (46)
- Porphyrin and chlorophyll metabolism (44)
- Amyotrophic lateral sclerosis (ALS) (43)
- Arachidonic acid metabolism (43)
- Prostate cancer (43)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (42)
- O-Glycan biosynthesis (42)
- Sphingolipid metabolism (42)
- Toll-like receptor signaling pathway (42)
- Epithelial cell signaling in Helicobacter pylori infection (41)
- Keratan sulfate biosynthesis (41)
- Androgen and estrogen metabolism (40)
- Wnt signaling pathway (40)
- Basal cell carcinoma (37)
- Fatty acid metabolism (35)
- Heparan sulfate biosynthesis (35)
- Primary immunodeficiency (35)
- Vibrio cholerae infection (35)
- Melanoma (34)
- T cell receptor signaling pathway (33)
- TGF-beta signaling pathway (33)
- Notch signaling pathway (32)
- Asthma (31)
- Chondroitin sulfate biosynthesis (31)
- Pentose and glucuronate interconversions (31)
- p53 signaling pathway (31)
- Complement and coagulation cascades (30)
- Ether lipid metabolism (30)
- Fc gamma R-mediated phagocytosis (30)
- Pancreatic cancer (30)
- Ascorbate and aldarate metabolism (29)
- Glutathione metabolism (28)
- Glycosphingolipid biosynthesis - globo series (27)
- Linoleic acid metabolism (27)
- Pyrimidine metabolism (27)
- Glycosphingolipid biosynthesis - ganglio series (26)
- Hedgehog signaling pathway (26)
- B cell receptor signaling pathway (25)
- Prion diseases (25)
- Glycerolipid metabolism (24)
- Tyrosine metabolism (23)
- Cytosolic DNA-sensing pathway (20)
- Fc epsilon RI signaling pathway (20)
- Progesterone-mediated oocyte maturation (20)
- Biosynthesis of unsaturated fatty acids (19)
- Renin-angiotensin system (19)
- Steroid biosynthesis (19)
- Oocyte meiosis (18)
- Bladder cancer (17)
- Riboflavin metabolism (17)
- Small cell lung cancer (17)
- Chronic myeloid leukemia (16)
- Insulin signaling pathway (16)
- Glycosaminoglycan degradation (14)
- Non-small cell lung cancer (14)
- Endometrial cancer (13)
- Galactose metabolism (13)
- Glioma (13)
- Nicotinate and nicotinamide metabolism (13)
- Pathogenic Escherichia coli infection (13)
- Renal cell carcinoma (13)
- alpha-Linolenic acid metabolism (12)
- Cyanoamino acid metabolism (11)
- Phosphatidylinositol signaling system (11)
- Primary bile acid biosynthesis (11)
- Selenoamino acid metabolism (11)
- Taurine and hypotaurine metabolism (11)
- Ubiquitin mediated proteolysis (11)
- Inositol phosphate metabolism (10)
- VEGF signaling pathway (10)
- Amino sugar and nucleotide sugar metabolism (9)
- RIG-I-like receptor signaling pathway (9)
- Phenylalanine metabolism (8)
- Protein export (8)
- Glycine (7)
- beta-Alanine metabolism (7)
- serine and threonine metabolism (7)
- C21-Steroid hormone metabolism (6)
- Caffeine metabolism (6)
- Dorso-ventral axis formation (6)
- Glycolysis / Gluconeogenesis (6)
- Nitrogen metabolism (6)
- O-Mannosyl glycan biosynthesis (6)
- Propanoate metabolism (6)
- Sulfur metabolism (6)
- Thyroid cancer (6)
- Tryptophan metabolism (6)
- Citrate cycle (TCA cycle) (5)
- NOD-like receptor signaling pathway (5)
- Valine (5)
- leucine and isoleucine degradation (5)
- Acute myeloid leukemia (4)
- Limonene and pinene degradation (4)
- Arginine and proline metabolism (3)
- Base excision repair (3)
- Cell cycle (3)
- Fatty acid elongation in mitochondria (3)
- Histidine metabolism (3)
- Lysine degradation (3)
- Maturity onset diabetes of the young (3)
- Other glycan degradation (3)
- Pantothenate and CoA biosynthesis (3)
- Pyruvate metabolism (3)
- Butanoate metabolism (2)
- Terpenoid backbone biosynthesis (2)
- Fatty acid biosynthesis (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)